📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. (2022)

First Author: Lin J

Attributed to: Sulphides - Economically important geochemical messengers from the mantle funded by NERC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.1022598

PubMed Identifier: 36505399

Publication URI: http://europepmc.org/abstract/MED/36505399

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in immunology

ISSN: 1664-3224